Farah Ahmad
Executive Vice President Business Development
Expertise:
Farah Ahmad is the Executive Vice President of Business Development at EVERSANA, where she leads the business development team targeting the North American market for small to mid-sized pharma and biotech companies. She previously served as President of Life Sciences at Press Ganey, where she spearheaded the development of innovative products and strategic partnerships. Farah’s extensive experience includes roles at Valsoft Corporation, Clinical Maestro, and Syneos Health, showcasing her expertise in strategic business development and commercialization.
Articles by Farah Ahmad
Capital Efficient Commercialization: A New Model for Success
In today’s fiscal environment, efficient capital allocation is crucial for success. Biopharma companies can take advantage of new approaches to commercialization to dramatically reduce the capital burden to launch their products. Building Your Own Commercial Infrastructure Is a Waste of Capital The technology, infrastructure, and full-time staff required for a successful launch can drain millions of dollars from your budget. Overinvesting in these areas not only adds to excessive costs but also carries significant risks if timelines shift due to regulatory and business challenges. By attempting to build their own commercial infrastructure companies often find themselves burdened with high fixed costs and operational expenses that could have been avoided. Now […]
Boosting Pharma Efficiency: A New Model for Asset Value Retention
In the pharmaceutical industry, maintaining asset value is challenging. Traditionally, companies either licensed their products or built their own commercial setup, each option with its own risks. But what if there were a powerful alternative that boosts efficiency, saves costs, leverages multi-brand expertise, and maximizes revenue potential and asset value—all without the hassle of complex systems? Out-licensing is a Bad Bargain Out-licensing is a common strategy for clinical-stage companies to bring products to market through a commercial-stage pharma partner However, it often comes at a significant cost, with companies sacrificing up to 80% of the net present value (NPV) of their asset. While it provides a short-term economic boost, it […]
The Path to Maximizing Revenue: How to Simplify Pharmaceutical Commercialization and Find Optimum Success
For pharmaceutical manufacturers, achieving optimal revenue in a competitive landscape is a multifaceted challenge that requires strategic foresight and meticulous execution. Small and emerging biotech companies often face significant hurdles in reaching maximum commercial success. In this blog, we explore the critical factors that influence revenue maximization and why companies must adopt a forward-thinking, integrated approach to unlock their full revenue potential. We also delve into why working with a dedicated commercialization partner with proven expertise and comprehensive services can help transform challenges into opportunities. The Importance of Early Commercial Strategy One of the primary reasons companies struggle to maximize revenue is the late initiation of strategic commercial planning. Decisions […]